Terminal differentiation of spontaneous rheumatoid factor-secreting B cells from rheumatoid arthritis patients depends on endogenous interleukin-10

被引:43
作者
Perez, L
Orte, J
Brieva, JA
机构
[1] HOSP UNIV PUERTA MAR,SERV IMMUNOL,E-11009 CADIZ,SPAIN
[2] HOSP RAMON Y CAJAL,E-28034 MADRID,SPAIN
来源
ARTHRITIS AND RHEUMATISM | 1995年 / 38卷 / 12期
关键词
D O I
10.1002/art.1780381210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The presence of serum rheumatoid factor (RF) and spontaneous RF-secreting B cells is a common feature in most patients with rheumatoid arthritis (RA), This study analyzed the cytokine(s) that controls the final maturation of B cells capable of spontaneous IgM-RF secretion in vitro. Methods. RA patients' peripheral blood mononuclear cells (PBMC), as well as adherent and nonadherent cell fractions, were cultured, and spontaneous IgM-RF and interleukin-10 (IL-10) secretion were determined by enzyme-linked immunosorbent assay. Results. The RF+ RA PBMC, but not PBMC from RF- RA patients or healthy controls, actively produced IgM-RF in a linear manner for 14 days, This activity depended on the presence of fetal calf serum and did not require cellular DNA synthesis, Spontaneous IgM-RF secretion depended on IL-10, as deduced from the following findings: 1) IL-10, but not a variety of cytokines including IL-6, restored missing IgM-RF secretion by PBMC in serum-free supplemented cultures; 2) the addition of anti-IL-10, but not anti-IL-6, blocking antibodies inhibited PBMC IgM-RF secretion, and this effect could be reversed by exogenous IL-10; and 3) RA PBMC actively produced IL-10 in vitro, The cells responsible for endogenous IL-10 production were found in the adherent cell fraction, Finally, IL-10 induced IgM-RF, but not total IgM, secretion by RA PBMC. Conclusion. In patients with RA, circulating B cells capable of spontaneous IgM-RF secretion require IL-10 production by adherent cells to reach terminal maturation.
引用
收藏
页码:1771 / 1776
页数:6
相关论文
共 27 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]  
BRENNAN FM, 1990, CLIN EXP IMMUNOL, V81, P278
[3]   HUMAN TONSIL, BLOOD AND BONE-MARROW IN-VIVO INDUCED B-CELLS CAPABLE OF SPONTANEOUS AND HIGH-RATE IMMUNOGLOBULIN SECRETION IN-VITRO - DIFFERENCES IN THE REQUIREMENTS FOR FACTORS AND FOR ADHERENT AND BONE-MARROW STROMAL CELLS, AS WELL AS DISTINCTIVE ADHESION MOLECULE EXPRESSION [J].
BRIEVA, JA ;
ROLDAN, E ;
RODRIGUEZ, C ;
NAVAS, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (02) :362-366
[4]  
CALLAGHAN M, 1993, CLIN EXP IMMUNOL, V93, P212
[5]   INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SERA AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATIC DISEASES [J].
COPE, AP ;
ADERKA, D ;
DOHERTY, M ;
ENGELMANN, H ;
GIBBONS, D ;
JONES, AC ;
BRENNAN, FM ;
MAINI, RN ;
WALLACH, D ;
FELDMANN, M .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1160-1169
[6]   ELEVATED INTERLEUKIN-10 LEVELS IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
CUSH, JJ ;
SPLAWSKI, JB ;
THOMAS, R ;
MCFARLIN, JE ;
SCHULZEKOOPS, H ;
DAVIS, LS ;
FUJITA, K ;
LIPSKY, PE .
ARTHRITIS AND RHEUMATISM, 1995, 38 (01) :96-104
[7]   THE ABILITY OF SYNOVIOCYTES TO SUPPORT TERMINAL DIFFERENTIATION OF ACTIVATED B-CELLS MAY EXPLAIN PLASMA-CELL ACCUMULATION IN RHEUMATOID SYNOVIUM [J].
DECHANET, J ;
MERVILLE, P ;
DURAND, I ;
BANCHEREAU, J ;
MIOSSEC, P .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :456-463
[8]  
DELEURAN BW, 1992, BRIT J RHEUMATOL, V31, P801
[9]  
DUMBAR BS, 1990, METHOD ENZYMOL, V182, P663
[10]   SYNOVIUM AS A SOURCE OF INTERLEUKIN 6 INVITRO - CONTRIBUTION TO LOCAL AND SYSTEMIC MANIFESTATIONS OF ARTHRITIS [J].
GUERNE, PA ;
ZURAW, BL ;
VAUGHAN, JH ;
CARSON, DA ;
LOTZ, M .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (02) :585-592